USPSTF: Starting Aspirin in Patients 60 or Older for Primary CVD Prevention Not Recommended
Starting aspirin in patients 60 years or older to prevent a first heart attack or stroke is not recommended.
Stroke
Migraine Management: How to Treat Patients With Vascular Disease
The use of triptans is contraindicated in patients with migraine and a history of ischemic stroke or coronary artery disease, although there is no substantial evidence that they directly increase the risk for vascular events.
Top August & September 2021 FDA Approvals
August and September 2021 FDA drug approvals include treatments for tick-borne encephalitis, idiopathic hypersomnia, schizophrenia, and atopic dermatitis.
AHA Presidential Statement: The Link Between Opioid Use, CVD, and Stroke
The AHA has issued a Presidential Advisory Statement outlining considerations for addressing the effects of opioids on cardiovascular and neurovascular health.
Metabolic Syndrome Linked to Increased Risk for Stroke Recurrence
Low levels of HDL cholesterol and having 2 or more components of metabolic syndrome predict stroke recurrence
AHA Releases Scientific Statement on Sleep-Disordered Breathing and Cardiovascular Disease
The AHA outlines screening, diagnosis, and treatment recommendations for obstructive sleep apnea and CV complications tied to the sleep disorder.
Clinicians Must Go Beyond FAST When Diagnosing Acute Stroke
Researcher describes the limitations of currently available stroke screening tools and recent modifications made to these tools to improve diagnostic accuracy.
AHA/ASA 2021 Guidelines for Secondary Stroke Prevention
Here are highlights from the American Heart Association and American Stroke Association’s 2021 evidence-based guidelines for preventing another stroke after a first stroke or transient ischemic attack.
Preeclampsia May Be a Risk Factor for Later-Life Stroke
A team of investigators conducted a population-based cohort study to determine whether preeclampsia history affected the relative risk for incident stroke.
Long-Term BP Variability Linked to Cardiovascular Mortality in T2D
Greater variability in systolic blood pressure and diastolic blood pressure was associated with increased CVD mortality risk in T2D.
- Loading...
Loading...
Next post in Type 2 Diabetes Information Center
Loading... 
Loading...